Association Between Reduced Handgrip Strength and Commonly Prescribed Medications

Autor: Norris Lb, Mitchell Em, Bryan L. Love

Decreased handgrip-strength has become an increasingly important measure of overall health status and fitness. This was a cross-sectional analysis among adult participants in the 2011-2012 NHANES survey. Handgrip-strength was assessed using a digital

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c0c837fd1571b13d11637eedf83c9b

Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies.

Autor: Smalls DJ; Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina., Kiger RE; Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina., Norris LB; Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina.; South Carolina Center of Economic Excellence for Medication Safety, University of South Carolina College of Pharmacy, Columbia, South Carolina., Bennett CL; Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina.; South Carolina Center of Economic Excellence for Medication Safety, University of South Carolina College of Pharmacy, Columbia, South Carolina.; William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina.; Arnold School of Public Health, University of South Carolina, Columbia, South Carolina.; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina., Love BL; Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina.; South Carolina Center of Economic Excellence for Medication Safety, University of South Carolina College of Pharmacy, Columbia, South Carolina.; William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina.

Publikováno v: Pharmacotherapy [Pharmacotherapy] 2019 Dec; Vol. 39 (12), pp. 1190-1203. Date of Electronic Publication: 2019 Nov 03.

Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.

Autor: Chen B; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.; Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina, USA., Nagai S; Translational Research Center, The University of Tokyo Hospital, Tokyo, Japan., Armitage JO; University of Nebraska School of Medicine, Omaha, Nebraska, USA., Witherspoon B; College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Nabhan C; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Godwin AC; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Yang YT; Center for Health Policy and Media Engagement, George Washington University, Washington, D.C., USA., Kommalapati A; School of Medicine, University of South Carolina, Columbia, South Carolina, USA., Tella SH; School of Medicine, University of South Carolina, Columbia, South Carolina, USA., DeAngelis C; Sunnybrook Health Sciences Center, Toronto, Ontario, Canada., Raisch DW; College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA., Sartor O; Tulane University School of Medicine, New Orleans, Louisiana, USA., Hrushesky WJ; Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA., Ray PS; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Yarnold PR; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Love BL; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Norris LB; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Knopf K; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.; Alameda Health System, Oakland, California, USA., Bobolts L; Oncology Analytics Inc., Plantation, Florida, USA.; Nova Southeastern University College of Pharmacy, Fort Lauderdale, Florida, USA., Riente J; William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina, USA., Luminari S; Hematology, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.; Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy., Kane RC; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Hoque S; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Bennett CL; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA bennettc@cop.sc.edu.; Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.; William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina, USA.

Publikováno v: The oncologist [Oncologist] 2019 Apr; Vol. 24 (4), pp. 537-548. Date of Electronic Publication: 2019 Mar 06.

Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.

Autor: Bennett CL; The Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA.; The Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.; SC Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Berger JR; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Sartor O; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Carson KR; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO, USA., Hrushesky WJ; The Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA.; The Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.; SC Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Oncology Analytics Inc, Plantation, FL, USA., Georgantopoulos P; The Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA.; The Arnold School of Public Health, University of South Carolina, Columbia, SC, USA., Raisch DW; College of Pharmacy, Pharmacoeconomics, Epidemiology, Public Policy, Outcomes Research Program, University of New Mexico, Albuquerque, NM, USA., Norris LB; The Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA., Armitage JO; The University of Nebraska Medical Center, Omaha, NE, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2018 Jan; Vol. 180 (2), pp. 301-304. Date of Electronic Publication: 2016 Sep 21.

Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients.

Autor: Norris LB; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA. Electronic address: lnorris@cop.sc.edu., Kablaoui F; Cleveland Clinic, Abu Dhabi, United Arab Emirates., Brilhart MK; Wake Forest Baptist Medical Center, Winston-Salem, NC, USA., Bookstaver PB; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA.

Publikováno v: International journal of antimicrobial agents [Int J Antimicrob Agents] 2017 Sep; Vol. 50 (3), pp. 308-317. Date of Electronic Publication: 2017 Jul 06.